ArticlesBaricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19. Management of Allergic Patients During the COVID-19 Pandemic in Asia. Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: Comparing a single surgical site with a COVID-19 intensive care unit. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. Concerns related to the COVID-19 pandemic in adult patients with atopic dermatitis and psoriasis treated with systemic immunomodulatory therapy: a Danish questionnaire survey. Dupilumab in atopic dermatitis, a protocol for SARS-COV 2 infected patients. COVID-19 reopening causes high risk of irritant contact dermatitis in children. Change of dermatological practice after the COVID-19 outbreak resolves. A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services. Patient-Driven Discontinuation of Dupilumab During the COVID-19 Pandemic in Two Academic Hospital Clinics at the University of Toronto. SARS‐CoV‐2 receptor ACE2 protein expression in serum is significantly associated with age COVID-19 and implications for dermatological and allergological diseases. Hand eczema due to frequent hand washing in combat with COVID-19. High incidence of hand eczema in Danish school children following intensive hand hygiene during the COVID-19 pandemic - a nationwide questionnaire study. Hand Hygiene Practices and Risk and Prevention of Hand Eczema during the COVID-19 Pandemic. Cutaneous manifestations and considerations in COVID-19 pandemic: A systematic review. Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID-19 pandemic. 4-month-old boy coinfected with COVID-19 and adenovirus. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome? Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model. Live-interactive teledermatology program in Taiwan: One-year experience serving a district hospital in rural Taitung County. Therapeutic approach to skin reactions caused by personal protective equipment (PPE) during COVID-19 pandemic: An experience from a tertiary hospital in Granada, Spain. Molecular docking, simulation and MM-PBSA studies of nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic. The risk of hand eczema in healthcare workers during the COVID-19 pandemic: Do we need specific attention or prevention strategies? Distribution of ACE2, CD147, CD26 and Other SARS-CoV-2 Associated Molecules in Tissues and Immune Cells in Health and in Asthma, COPD, Obesity, Hypertension, and COVID-19 Risk Factors. U Radzikowska, M Ding, G Tan, D Zhakparov, Y Peng, P Wawrzyniak, et al. Allergy. 2020 Jun 4 (Online ahead of print) https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14429 Considerations on Biologicals for Patients with allergic disease in times of the COVID-19 pandemic: an EAACI Statement. Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID-19 pandemic: A single-center real-life experience. Hand eczema pandemic caused by severe acute respiratory syndrome coronavirus 2 hygiene measures: the set-up of a hand eczema helpline for hospital personnel. Influence of COVID-19 pandemic on hospitalizations at the tertiary dermatology department in south-west Poland. The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Considerations for Safety in the Use of Systemic Medications for Psoriasis and Atopic Dermatitis during the COVID-19 pandemic. J. Ricardo and S. Lipner. Dermatol Ther. 2020 May 27. DOI: 10.1111/dth.13687. COMMENTARY BY: Yael Renert-Yuval, MD, Instructor in Clinical Investigation, Laboratory for Investigative Dermatology, Rockefeller University. The Fear of COVID-19 Infection Is the Main Cause of the New Diagnoses of Hand Eczema: Report From the Frontline in Milan (PMID: 32436317) Giacalone, S, Bortoluzzi, P, Nazzaro, G. Dermatol Ther 2020 May 20 https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.13630 COVID-19, quarantine, and atopic dermatitis. Cataldo Patruno, Steven Paul Nisticò, Gabriella Fabbrocini, and Maddalena Napolitano. Med Hypotheses. 2020 Oct. Published online 2020 May 19 https://www.sciencedirect.com/science/article/pii/S0306987720310793?via%3Dihub Safety of Dupilumab in Atopic Patients During COVID-19 Outbreak (PMID: 32419563) Napolitano, M, Patruno, C, Ruggiero, A, Nocerino, M, Fabbrocini, GJ. Dermatolog Treat. 2020 May 18 COVID-19 Knowledge Prevents Biologics Discontinuation: Data From an Italian Multi-Center Survey During RED-ZONE Declaration (PMID: 32415727) Bragazzi, NL, Riccò, M, Pacifico, A, Piergiorgio, M, COVID19 Dermatological Task Force, Young Dermatologists Italian Network; Kridin, K, Pigatto, P, Damiani, G. Dermatol Ther. 2020 May 16 https://onlinelibrary.wiley.com/doi/epdf/10.1111/dth.13508 Optimizing Care for Atopic Dermatitis Patients During COVID-19 Pandemic (PMID: 32405123) Shah, M, Sachdeva, M, Alavi, A, Shi, VY, Hsiao, JL. J Am Acad Dermatol 2020 May 13 https://doi.org/10.1016/j.jaad.2020.05.027 SARS-CoV-2 Asymptomatic Infection in a Patient Under Treatment With Dupilumab (PMID: 3238643) Caroppo, F, Biolo, G, Belloni Fortina, A. J Am Acad Dermatol 2020 May 9 https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16619 COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic (PMID: 32224232) Shaker, MS, Oppenheimer, J, Grayson, M, Stukus, D, Hartog, N, Hsieh, EWY, Rider, B, Dutmer, CM, Vander Leek, TK. J Allergy Clin Immunol (5):1477-1488.e5. 2020 May 8 https://www.sciencedirect.com/science/article/pii/S2213219820302531?via%3Dihub Hand Eczema – A Growing Dermatological Concern During the COVID-19 Pandemic and Possible Treatments (PMID 32384196) Blicharz, L, Czuwara, J, Samochocki, Z, Goldust, M, Chrostowska, S, Olszewska, M, Rudnicka, L. Dermatol Ther. 2020 May 8 https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.13545 Dermatological Diseases Presented Before COVID-19: Are Patients With Psoriasis and Superficial Fungal Infections More Vulnerable to the COVID-19? (PMID: 32367558) Kutlu, O, Metin, A. Dermatol Ther. 2020 May 5 https://onlinelibrary.wiley.com/doi/abs/10.1111/dth.13509 Dupilumab and COVID-19: What Should We Expect? (PMID: 32362061) Patruno, C, Stingeni, L, Fabbrocini, G, Hansel, K, Napolitano. M. Dermatol Ther. 2020 May 2 https://onlinelibrary.wiley.com/doi/full/10.1111/dth.13502 Global Reporting of Cases of COVID-19 in Psoriasis and Atopic Dermatitis: An Opportunity to Inform Care During a Pandemic (PMID: 32348554) Mahil, SK, Yiu, ZZN, Mason, KJ, Dand, N, Coker, B, Wall, D. Br J Dermatol 2020 Apr 29 https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.19161 No Evidence of Increased Risk for COVID-19 Infection in Patients Treated With Dupilumab for Atopic Dermatitis in a High-Epidemic Area – Bergamo, Lombardy, Italy (PMID: 32339362) Carugno, A, Raponi,, Locatelli, A, Vezzoli, P, Gambini, DM, Di Mercurio, M, Robustelli Test, E, Sena, P. J Eur Acad Dermatol Venereol. 2020 Apr 27 https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16552 Safety of Dupilumab in Severe Atopic Dermatitis and Infection of Covid-19: Two Case Reports (PMID: 32330323) Ferrucci, S, Romagnuolo, M, Angileri, L, Berti, E, Tavecchio, S. J Eur Acad Dermatol Venereol 2020 Apr 24 https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16527 Mass Quarantine Measures in the Time of COVID-19 Pandemic: Psychosocial Implications for Chronic Skin Conditions and a Call for Qualitative Studies. S Garcovich, F S Bersani, A Chiricozzi, C De Simone. J Eur Acad Dermatol Venereol. 2020 Apr 24 (Online ahead of print). https://onlinelibrary.wiley.com/doi/full/10.1111/jdv.16535 Dermatologists and SARS-CoV-2: The Impact of the Pandemic on Daily Practice (PMID: 32320091) Gisondi, P, Piaserico, S, Conti, A, Naldi, L. J Eur Acad Dermatol Venereol 2020 Apr 22 https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16515 The Role of Occupational Dermatology in the COVID-19 Outbreak (PMID: 14065548) Patruno, C, Fabbrocini, G, Stingeni, L, Napolitano, M. Contact Dermatitis 2020 Apr 21 https://onlinelibrary.wiley.com/doi/abs/10.1111/cod.13568 Overzealous Hand Hygiene During the COVID 19 Pandemic Causing an Increased Incidence of Hand Eczema Among General Population (PMID: 32305441) Singh, M, Pawar, M, Bothra, A, Choudhary, N. J Am Acad Dermatol 2020 Apr 16 https://www.jaad.org/article/S0190-9622(20)30660-5/pdf Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic (PMID: 32277351), Torres, T, Puig, L. Am J Clin Dermatol 2020 Apr 10 https://link.springer.com/article/10.1007/s40257-020-00514-2 Frequent Hand Washing for COVID-19 Prevention Can Cause Hand Dermatitis: Management Tips (PMID: 32373409) Beui, C, Hihai, M, Popa, L, Cima, L, Popescu, MN. Cureus 2020 April 2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195203/ European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2)‐infection and atopic dermatitis (PMID 32223003) Wollenberg, A, Flohr, C, Simon, D, Cork, M, Thyssen, JP, Bieber, T, de Bruin-Weller, MS, Weidinger, S, Deleuran, M, Taieb, A, Paul, C, Trzeciak, M, Werfel, T, Seneschal, J, Barbarot, S, Darsow, U, Torrelo, A, Stalder, JF, Svensson, A, Hijnen, DJ, Gelmetti, C, Szalai, Z, Gieler, U, De Raeve, L, Kunz, B, Spuls, P, von Kobyletzki, LB, Folster-Holst, R, Chernyshov, PV, Cristen-Zaech, S, Heratizadeh, A, Ring, J, Vestergaard, C. J Eur Acad Dermatol Venereol. 2020 Mar 29. https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16411 |
Latest News
Announcements
The International Eczema Council is happy to announce its new three-year Strategic Plan. This in-depth process involved IEC leadership, Councilors, Associates and Industry Partners as we sought input through surveys and other methods.
Upcoming Events
Thu Mar 6, 2025IEC Councilor, Associate, Industry Partner Meeting at AAD 2025 - Orlando, FL, USA Category: Councilors |
